Benoist, G. E., van der Meulen, E., van Oort, I. M., Beumer, J. H., Somford, D. M., Schalken, J. A., . . . van Erp, N. P. (2018). Development and validation of a bioanalytical method to quantitate enzalutamide and its active metabolite N-desmethylenzalutamide in human plasma: Application to clinical management of metastatic castration-resistant prostate cancer patients. Ther Drug Monit.

Benoist, Guillemette E., Eric van der Meulen, Inge M. van Oort, Jan Hendrik Beumer, Diederik M. Somford, Jack A. Schalken, David M. Burger, and Nielka P. van Erp. "Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and Its Active Metabolite N-desmethylenzalutamide in Human Plasma: Application to Clinical Management of Metastatic Castration-resistant Prostate Cancer Patients." Ther Drug Monit 2018.

Benoist, Guillemette E., et al. "Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and Its Active Metabolite N-desmethylenzalutamide in Human Plasma: Application to Clinical Management of Metastatic Castration-resistant Prostate Cancer Patients." Ther Drug Monit 2018.